1. Home
  2. ARVN vs KE Comparison

ARVN vs KE Comparison

Compare ARVN & KE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • KE
  • Stock Information
  • Founded
  • ARVN 2015
  • KE 1961
  • Country
  • ARVN United States
  • KE United States
  • Employees
  • ARVN N/A
  • KE N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • KE Electrical Products
  • Sector
  • ARVN Health Care
  • KE Technology
  • Exchange
  • ARVN Nasdaq
  • KE Nasdaq
  • Market Cap
  • ARVN 456.2M
  • KE 459.3M
  • IPO Year
  • ARVN 2018
  • KE N/A
  • Fundamental
  • Price
  • ARVN $7.90
  • KE $29.28
  • Analyst Decision
  • ARVN Buy
  • KE Strong Buy
  • Analyst Count
  • ARVN 22
  • KE 1
  • Target Price
  • ARVN $20.21
  • KE $28.00
  • AVG Volume (30 Days)
  • ARVN 1.8M
  • KE 283.6K
  • Earning Date
  • ARVN 10-29-2025
  • KE 08-13-2025
  • Dividend Yield
  • ARVN N/A
  • KE N/A
  • EPS Growth
  • ARVN N/A
  • KE N/A
  • EPS
  • ARVN N/A
  • KE 0.68
  • Revenue
  • ARVN $372,800,000.00
  • KE $1,486,727,000.00
  • Revenue This Year
  • ARVN $4.87
  • KE N/A
  • Revenue Next Year
  • ARVN N/A
  • KE $4.02
  • P/E Ratio
  • ARVN N/A
  • KE $42.74
  • Revenue Growth
  • ARVN 299.57
  • KE N/A
  • 52 Week Low
  • ARVN $5.90
  • KE $12.41
  • 52 Week High
  • ARVN $29.61
  • KE $29.17
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 60.55
  • KE 87.67
  • Support Level
  • ARVN $7.62
  • KE $28.20
  • Resistance Level
  • ARVN $8.22
  • KE $29.11
  • Average True Range (ATR)
  • ARVN 0.31
  • KE 1.08
  • MACD
  • ARVN 0.10
  • KE 0.18
  • Stochastic Oscillator
  • ARVN 76.98
  • KE 99.86

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

Share on Social Networks: